MARTA MARIA
GARCIA CLEMENTE
Profesora Asociada en CC. Salud - LOSU
Hospital Universitario de la Princesa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (19)
2023
-
Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease
Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565
2022
-
Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes
Biomedicines, Vol. 10, Núm. 5
-
Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study
Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21
-
Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study
Biomedicines, Vol. 10, Núm. 2
2021
-
C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)
Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 21-27
-
Differences in nutritional status and inflammatory biomarkers between female and male patients with bronchiectasis: A large-cohort study
Biomedicines, Vol. 9, Núm. 8
-
Effect of Sex Differences on Computed Tomography Findings in Adults With Cystic Fibrosis: A Multicenter Study
Archivos de Bronconeumologia, Vol. 57, Núm. 4, pp. 256-263
-
Phenotypic clustering in non-cystic fibrosis bronchiectasis patients: The role of eosinophils in disease severity
International Journal of Environmental Research and Public Health, Vol. 18, Núm. 16
-
Predictive value of the modified Bhalla score for assessment of pulmonary exacerbations in adults with cystic fibrosis
European Radiology, Vol. 31, Núm. 1, pp. 112-120
-
Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis
Clinical Microbiology and Infection, Vol. 27, Núm. 3, pp. 428-434
-
Treatment of pulmonary disease of cystic fibrosis: A comprehensive review
Antibiotics, Vol. 10, Núm. 5
2020
-
COPD Assessment Test in Bronchiectasis: Minimum Clinically Important Difference and Psychometric Validation: A Prospective Study
Chest, Vol. 157, Núm. 4, pp. 824-833
-
Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years on
Archivos de Bronconeumologia, Vol. 56, Núm. 8, pp. 483-492
-
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey
Respiratory Medicine, Vol. 170
-
Impact of pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases
Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-32
2018
-
Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience
Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618
-
Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience
Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618
-
Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis
Respiration, Vol. 96, Núm. 5, pp. 406-416
2016
-
Factors associated with fatality during the intensive phase of anti-tuberculosis treatment
PLoS ONE, Vol. 11, Núm. 8